Pharmaceutical - Mergers & Acquisitions

Filter

Current filters:

Mergers & Acquisitions

Popular Filters

51 to 75 of 650 results

Patent expiry and increasing generic competition is expected to make a handful of mega deals happen

Patent expiry and increasing generic competition is expected to make a handful of mega deals happen

13-05-2014

The challenges posed by expiring patents, the global economic slowdown, and price premium pressures are…

Mergers & AcquisitionsPatentsPharmaceutical

Allergan board totally rejects Valeant’s $46 billion bid

Allergan board totally rejects Valeant’s $46 billion bid

13-05-2014

USA-based Allergan said yesterday that its board of directors has unanimously rejected the $46 billion…

AllerganMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Merck & Co sells ophthalmic brands and Colorado biologicals unit

Merck & Co sells ophthalmic brands and Colorado biologicals unit

13-05-2014

US pharma giant Merck & Co has entered into two more divestment transactions, following the recent sell-off…

KBI BiopharmaMerck & CoMergers & AcquisitionsOphthalmicsPharmaceuticalProductionSanten Pharmaceuticals

Shire acquires Lumena Pharma, adding to rare disease portfolio

Shire acquires Lumena Pharma, adding to rare disease portfolio

12-05-2014

Ireland-headquartered drugmaker Shire says it will acquire San Diego, USA-based rare disease focussed…

Lumena PharmaceuticalsMergers & AcquisitionsPharmaceuticalRare diseasesShire

Riemser Pharma acquires French drugmaker Keocyt

12-05-2014

German specialty pharmaceutical company Riemser Pharma (formerly Riemser Arzneimittel) said today that…

KeocytMergers & AcquisitionsOncologyPharmaceuticalRare diseasesRiemser Pharma

Merck KGaA may look to biosimilars and acquisitions for growth

Merck KGaA may look to biosimilars and acquisitions for growth

12-05-2014

German pharma and chemical major Merck KGaA has said it is planning to invest in innovations to ensure…

BiosimilarsLicensingMerck KGaAMergers & AcquisitionsPharmaceutical

Takeover target Allergen reports strong 1st-qtr sales growth

07-05-2014

US drugmaker Allergan reported a strong set of first-quarter 2014 financial results, with global sales…

AllerganFinancialMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

AstraZeneca sets out its value stall, projecting annual revenues of $45 billion by 2023

AstraZeneca sets out its value stall, projecting annual revenues of $45 billion by 2023

06-05-2014

In a bid to explain its rejection of US pharma giant Pfizer’s increased takeover bid for the Anglo-Swedish…

AstraZenecaFinancialMergers & AcquisitionsPfizerPharmaceuticalResearch

Bayer shells out $14.2 billion for Merck & Co OTC business; firms to collaborate on sGC modulators

Bayer shells out $14.2 billion for Merck & Co OTC business; firms to collaborate on sGC modulators

06-05-2014

Confirming strong rumors over the past week or so, German pharma major Bayer confirmed it has agreed…

AdempasBayerLicensingMerck & CoMergers & AcquisitionsPharmaceuticalResearchRespiratory and Pulmonaryvericiguat

Pfizer’s 4th-qtr 2014 profits and sales slump on generic competition

Pfizer’s 4th-qtr 2014 profits and sales slump on generic competition

06-05-2014

US pharma giant Pfizer, which is aggressively pursuing a takeover of Anglo-Swedish drug major AstraZeneca,…

AstraZenecaFinancialMergers & AcquisitionsPfizerPharmaceutical

AstraZeneca board rejects Pfizer’s increased offer

AstraZeneca board rejects Pfizer’s increased offer

02-05-2014

Within just a few hours of US pharma giant Pfizer announcing an increased offer price for Anglo-Swedish…

AstraZenecaMergers & AcquisitionsPfizerPharmaceutical

Pfizer sweetens takeover offer for AstraZeneca to £50 a share

Pfizer sweetens takeover offer for AstraZeneca to £50 a share

02-05-2014

After much speculation and a lightning visit by Pfizer’s chief executive Ian Read to the UK to woo…

AstraZenecaMergers & AcquisitionsPfizerPharmaceutical

Forest Labs to acquire Furiex Pharma in $1.46 billion deal

29-04-2014

US drugmaker Forest Laboratories has entered into a definitive agreement to acquire Furiex Pharmaceuticals…

eluxadolineForest LaboratoriesFuriex PharmaceuticalsGastro-intestinalsMergers & AcquisitionsPharmaceuticalRoyalty Pharma

AstraZeneca says Pfizer offer “very significantly” undervalues the firm

28-04-2014

Confirming a takeover approach from the US drugs giant, Anglo-Swedish pharma major AstraZeneca issued…

AstraZenecaMergers & AcquisitionsOncologyPfizerPharmaceutical

Fresenius Kabi signs joint venture with Russia’s Binnopharm

Fresenius Kabi signs joint venture with Russia’s Binnopharm

28-04-2014

Germany-based health care group Fresenius Kabi is entering into a joint venture with Russia’s Sistema…

BinnopharmBusiness FinanceBusiness FinanceFinancialFreseniusFresenius KabiGermanyHealth careHealthcareMergers & AcquisitionsPharmaceuticalRussiaUSD

Pfizer goes public, confirming pursuit of AstraZeneca

Pfizer goes public, confirming pursuit of AstraZeneca

28-04-2014

US pharma giant Pfizer this morning confirmed that it previously submitted a preliminary, non-binding…

AstraZenecaMergers & AcquisitionsPfizerPharmaceutical

Sweden’s Meda reportedly gets raised bid from Mylan

Sweden’s Meda reportedly gets raised bid from Mylan

28-04-2014

Having formally rejected an unsolicited takeover offer from US generics group Mylan earlier this month,…

MedaMergers & AcquisitionsMylanPharmaceutical

Allergan adopts stockholder rights plan

23-04-2014

USA-based Allergan, the subject of a hostile takeover bid from Canada’s Valeant Pharmaceuticals reported…

AllerganFinancialMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Health care M&A activity in 1st-qtr 2014 softens compared with 4th-qtr 2013; report

23-04-2014

Health care merger and acquisition activity was a little soft in the first quarter of 2014. Deal volume…

Mergers & AcquisitionsPharmaceutical

Valeant joins with hedge fund in $45.6 billion unsolicited bid for Allergan

22-04-2014

Canada’s Valeant Pharmaceuticals International, never shy to go for hostile takeover moves, says it…

AllerganMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Novartis swaps products with GlaxoSmithKline, sells unit to Lilly

Novartis swaps products with GlaxoSmithKline, sells unit to Lilly

22-04-2014

In what looks like a significant restructuring of company focuses, Swiss drug major Novartis and UK peer…

Eli LillyGlaxoSmithKlineMergers & AcquisitionsNovartisPharmaceuticalVaccines

Pfizer said to be eyeing a $100 billion bid for AstraZeneca

20-04-2014

USA-based Pfizer, the world’s largest pharma company by sales, looks to be on the acquisition trail,…

AstraZenecaMergers & AcquisitionsPfizerPharmaceutical

OPKO to buy Israel’s Inspiro, gaining rights to new drug delivery technology

18-04-2014

US biopharma company OPKO Health has entered into a definitive agreement to acquire Inspiro Medical an…

Inspiro MedicalMergers & AcquisitionsOPKO HealthPharmaceuticalRespiratory and Pulmonary

51 to 75 of 650 results

Back to top